Copyright© exclusive license and exclusive authorization
Editorial Board of China Oncology:
We agree that once this paper (paper title: ) is accepted and would be published in the journal China Oncology, we agree to grant the copyright and agency right of this paper to the Editorial Board of China Oncology. Editorial Board of China Oncology has the following exclusive rights to use this article: Copyright of compilation works (part or all of the article), distribution right, copy right of printed and electronic version, translation right, the right of information propagation on network, and act for domestic and foreign literature retrieval system or database collection right. China Oncology permits the third party to reuse is defined by the CC-BY-NC-ND 4.0 license. This license allows users to copy and distribute the article, provided: · This is not done for commercial purposes and further does not permit distribution of the Article if it is changed or edited in any way. · The user gives appropriate credit (with a link to the formal publication through the relevant DOI) and provides a link to the license but not in an any way implying that the licensor is endorsing the user or the use of the work. · No derivatives including remix, transform, or build upon the material was allowed for distribution.
We guarantee that this article is an original work, without duplicate publications, and does not involve confidentiality and other infringement issues related to intellectual property rights. In case of infringement, leakage and other issues, all responsibilities shall be ours.
This letter of authorization shall come into effect on the date of acceptance of this article by China Cancer Journal. It is valid until December 31 of the 50th year after the publication of the paper.
Author's signature (please fill in according to the order of the author's rank):
Correspondence to: E-mail:
Please send this authorization back to the Editorial Board of China Oncology. The article will be published after this authorization is signed and takes into effect.
The Ministry of Education of the People’s Republic of China
Fudan University Shanghai Cancer Center
Editorial Board of China Oncology
TANG Zhaoyou, CAO Shilong
Shanghai Ouyang Printing Co., Ltd.